Status:
COMPLETED
The Factors Causing Treatment Failure in Children Receiving Oxygen Therapy With High-flow Nasal Cannula
Lead Sponsor:
Dr. Behcet Uz Children's Hospital
Conditions:
High-flow Nasal Cannula
Respiratory Distress
Eligibility:
All Genders
1-18 years
Brief Summary
The goal of this observational study is to identify the variables that predict treatment failure in order to identify the patients in which HFNC treatment may fail and not delay the transition to adva...
Detailed Description
Oxygen therapy with a high-flow nasal cannula (HFNC) is a well-tolerated, relatively new, non-invasive alternative ventilation treatment modality. On the other hand, HFNC failure delays advanced respi...
Eligibility Criteria
Inclusion
- Moderate to severe respiratory distress
- Oxygen therapy with high-flow nasal cannula
Exclusion
- Chronic lung disease (those with CO2 retention or hypoxia in their daily life)
- Cyanotic congenital heart disease
- Craniofacial malformation
- Trauma patients
- Hypotonic patients
- Cases with tracheostomy
- Patients using HFNC therapy for respiratory support after extubation
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT06146439
Start Date
October 1 2018
End Date
February 1 2020
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Behcet Uz Children's Hospital
Izmir, Turkey (Türkiye)